IL69505A - Aqueous pharmaceutical compositions containing perfluorinated compounds and pharmaceutical preparations for treatment including control of growth of hypoxic tumor cells - Google Patents

Aqueous pharmaceutical compositions containing perfluorinated compounds and pharmaceutical preparations for treatment including control of growth of hypoxic tumor cells

Info

Publication number
IL69505A
IL69505A IL69505A IL6950583A IL69505A IL 69505 A IL69505 A IL 69505A IL 69505 A IL69505 A IL 69505A IL 6950583 A IL6950583 A IL 6950583A IL 69505 A IL69505 A IL 69505A
Authority
IL
Israel
Prior art keywords
growth
tumor cells
compositions containing
including control
treatment including
Prior art date
Application number
IL69505A
Other languages
English (en)
Other versions
IL69505A0 (en
Original Assignee
Sun Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL69505(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Tech Inc filed Critical Sun Tech Inc
Publication of IL69505A0 publication Critical patent/IL69505A0/xx
Publication of IL69505A publication Critical patent/IL69505A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL69505A 1982-08-17 1983-08-16 Aqueous pharmaceutical compositions containing perfluorinated compounds and pharmaceutical preparations for treatment including control of growth of hypoxic tumor cells IL69505A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40858982A 1982-08-17 1982-08-17
US51715083A 1983-07-25 1983-07-25

Publications (2)

Publication Number Publication Date
IL69505A0 IL69505A0 (en) 1983-11-30
IL69505A true IL69505A (en) 1990-03-19

Family

ID=27020315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69505A IL69505A (en) 1982-08-17 1983-08-16 Aqueous pharmaceutical compositions containing perfluorinated compounds and pharmaceutical preparations for treatment including control of growth of hypoxic tumor cells

Country Status (19)

Country Link
EP (1) EP0105584B1 (ko)
JP (1) JPS59501665A (ko)
KR (1) KR890002204B1 (ko)
AU (1) AU559559B2 (ko)
CA (1) CA1225027A (ko)
CH (1) CH665952A5 (ko)
DE (2) DE3390172T1 (ko)
ES (1) ES8502405A1 (ko)
FI (1) FI841513A0 (ko)
GB (1) GB2134787A (ko)
GR (1) GR79383B (ko)
IE (1) IE55618B1 (ko)
IL (1) IL69505A (ko)
NL (1) NL8320264A (ko)
NO (1) NO841519L (ko)
PH (2) PH25492A (ko)
PT (1) PT77204B (ko)
SE (1) SE8402098D0 (ko)
WO (1) WO1984000686A1 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
CA1257828A (en) * 1984-04-16 1989-07-25 William Mccormick Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
WO1993018748A1 (en) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
ATE428345T1 (de) 1998-07-09 2009-05-15 Curelight Medical Ltd Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe
US20040122492A1 (en) 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
GB0200721D0 (en) * 2002-01-14 2002-02-27 Univ Bristol Toxicity test
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828085A (en) * 1970-07-09 1974-08-06 Allied Chem Novel amidoamine oxides
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US4041086A (en) * 1972-02-07 1977-08-09 Sun Ventures, Inc. Process of manufacture of flourinated alkyladamantanes
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (ko) * 1973-10-05 1978-09-01
DE2524363A1 (de) * 1975-06-02 1976-12-16 Boehringer Sohn Ingelheim Neue pharmazeutische mittel
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
JPS5331209A (en) * 1976-09-03 1978-03-24 Hitachi Ltd Small compressor cylinder for refrigerating machine and production of same
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
JPS6033367B2 (ja) * 1978-11-24 1985-08-02 株式会社ミドリ十字 酸素運搬輸液
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
EP0031353B1 (en) * 1979-06-25 1984-08-08 Suntech, Inc. Use of perfluorocarbon as burn treatment
CA1181011A (en) * 1980-05-27 1985-01-15 Robert P. Geyer Perfluorinated n,n-dimethyl cyclohexylmethylamine and emulsions containing the same
GR78151B (ko) * 1982-04-05 1984-09-26 Alcon Lab Inc

Also Published As

Publication number Publication date
FI841513A (fi) 1984-04-16
IL69505A0 (en) 1983-11-30
DE3378954D1 (en) 1989-02-23
PH25027A (en) 1991-01-28
FI841513A0 (fi) 1984-04-16
IE831925L (en) 1984-02-17
KR840005660A (ko) 1984-11-15
WO1984000686A1 (en) 1984-03-01
GR79383B (ko) 1984-10-22
PT77204B (en) 1986-02-04
KR890002204B1 (ko) 1989-06-23
SE8402098L (sv) 1984-04-16
CA1225027A (en) 1987-08-04
IE55618B1 (en) 1990-11-21
JPS59501665A (ja) 1984-10-04
EP0105584A1 (en) 1984-04-18
NL8320264A (nl) 1984-07-02
PT77204A (en) 1983-09-01
ES524972A0 (es) 1985-01-01
GB2134787A (en) 1984-08-22
ES8502405A1 (es) 1985-01-01
EP0105584B1 (en) 1989-01-18
NO841519L (no) 1984-04-16
DE3390172T1 (de) 1984-11-29
CH665952A5 (de) 1988-06-30
PH25492A (en) 1991-07-24
SE8402098D0 (sv) 1984-04-16
AU559559B2 (en) 1987-03-12
AU1941383A (en) 1984-03-07

Similar Documents

Publication Publication Date Title
IL69505A (en) Aqueous pharmaceutical compositions containing perfluorinated compounds and pharmaceutical preparations for treatment including control of growth of hypoxic tumor cells
DE3372845D1 (en) Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof
HUT47576A (en) Process for production of 2-amin-purin-derivatives and medical compositions containing them as active substance
HUT43837A (en) Process for production of n-benzhydril-diazacycloalkylalcane-anilides and medical compounds containing thereof as active substance
HUT42479A (en) Process for production of derivatives of quinasoline and medical preparatives containing thereof as active substance
IL74848A0 (en) Implantable formulations of regulatory peptides with controlled release,and process for their preparation
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
GB2086390B (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
GB8828694D0 (en) Preparation for introducing active substance for regulating tanning into skin production & use thereof
NO833279L (no) Farmasoeytiske preparater for behandling av uoensket sammenvoksing
ZA816322B (en) N-oxides of n-oxacyclic-alkylpiperidines,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
HUT42510A (en) Process for preparing biologically active derivatives of humane gamma-interferone and pharmaceutical compositions containing such compounds
HUT40098A (en) Process for production of halogen-hidroxi-flavons and medical preparatives containing thereof as active substance
HUT41216A (en) Fungicide compositions containing derivatives of alpha-pyridyl-beta-phenyl-alkanols as active ingredients and process for preparing the active substances
ZA792939B (en) Membrane stabilizing compounds having b-receptor blocking activity,their preparation,method for treatment of arrhythmic conditions,and pharmaceutical preparations containing same
HUT40613A (en) Process for preparing aminoalcohol derivatives and pharmaceutical preparations containing these compounds as active substance
HUT43592A (en) Process for production of derivatives of nitrofurane and medical compounds containing thereof as active substance
HUT43580A (en) Process for production of derivatives of carbonic acid and medical compounds containing thereof as active substance
HUT45018A (en) Process for production of rapamicine-derivatives and medical compositions containing them as active substance
HUT40095A (en) Process for preparing polycyclyc compounds with biocidal effect and pharmaceutical compositions containing such active substance
HUT44480A (en) Process for production of derivatives of /substituted amin-alkyl-amin or piperazinil/-naphtalin-dion and medical compounds containing them as active substance
HUT47558A (en) Process for production of 12-halogene-forscoline derivatives and medical compositions containing them as active substance
HUT41818A (en) Process for preparing peptides for growth stimulation and pharmaceutical compositions containing such compounds as active substances
DE2966607D1 (en) Medicines containing as active ingredients compounds of the benzene-sulfone type; compounds of this type and process for their preparation
HUT40605A (en) Process for preparing quinone derivatives and preparations containing these compounds as active substance